Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
-
- Douglas Tremblay
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Maaike van Gerwen
- Department of Otolaryngology-Head and Neck Surgery,
-
- Mathilda Alsen
- Department of Otolaryngology-Head and Neck Surgery,
-
- Santiago Thibaud
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Alaina Kessler
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Sangeetha Venugopal
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Iman Makki
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Qian Qin
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Sirish Dharmapuri
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Tomi Jun
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Sheena Bhalla
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Shana Berwick
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Jonathan Feld
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- John Mascarenhas
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Kevin Troy
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Caroline Cromwell
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Andrew Dunn
- Division of Hospital Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
-
- William K. Oh
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
-
- Leonard Naymagon
- Division of Hematology and Medical Oncology, Tisch Cancer Institute,
抄録
<jats:p>Tremblay and colleagues asked whether patients receiving either routine anticoagulation or antiplatelet therapy for existing conditions prior to becoming ill with COVID-19 have different outcomes from patients receiving neither therapy. After matching for existing comorbidities, this retrospective observational study finds no evidence for an effect of prediagnosis anticoagulation on mortality.</jats:p>
収録刊行物
-
- Blood
-
Blood 136 (1), 144-147, 2020-07-02
American Society of Hematology